Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Showing 1-25 of 56 citing articles:

GRADE guidance 35: update on rating imprecision for assessing contextualized certainty of evidence and making decisions
Holger J. Schünemann, Ignacio Neumann, Monica Hultcrantz, et al.
Journal of Clinical Epidemiology (2022) Vol. 150, pp. 225-242
Open Access | Times Cited: 73
COVID-19 therapeutics
Daniele Focosi, Massimo Franchini, Fabrizio Maggi, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Closed Access | Times Cited: 10
Appropriate thromboprophylaxis strategy for COVID-19 patients on dosage, antiplatelet therapy, outpatient and post-discharge prophylaxis: a meta-analysis of randomized controlled trials
Jiahao Meng, Hang Tang, Yifan Xiao, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 8
Patterns of Prophylactic Anticoagulation Among Patients Hospitalized for COVID‐19: An Analysis of the American Heart Association COVID‐19 Cardiovascular Disease Registry
Mathew S. Lopes, Hsin‐Fang Li, Reed J D Sorensen, et al.
Journal of the American Heart Association (2025)
Open Access
Predictors of venous thromboembolic events in hospitalized patients with COVID-19
Giovanni Scimeca, Darsiya Krishnathasan, Sina Rashedi, et al.
Journal of Thrombosis and Thrombolysis (2025)
Closed Access
Increased Susceptibility for Thromboembolic Events versus High Bleeding Risk Associated with COVID-19
Cristina Tudoran, Dana Emilia Velimirovici, Delia Berceanu-Văduva, et al.
Microorganisms (2022) Vol. 10, Iss. 9, pp. 1738-1738
Open Access | Times Cited: 25
Anticoagulation Strategies in Non–Critically Ill Patients with Covid-19
Zoe McQuilten, Balasubramanian Venkatesh, Vivekanand Jha, et al.
NEJM Evidence (2022) Vol. 2, Iss. 2
Closed Access | Times Cited: 18
Antithrombin Therapy: Current State and Future Outlook
George M. Rodgers, Arash Mahajerin
Clinical and Applied Thrombosis/Hemostasis (2023) Vol. 29
Open Access | Times Cited: 11
Anticoagulação Crônica em Pacientes com Fibrilação Atrial e COVID-19: Uma Revisão Sistemática e Metanálise
Isabela Landsteiner, Jonathan A. Pinheiro, Nicole Felix, et al.
Arquivos Brasileiros de Cardiologia (2024) Vol. 121, Iss. 3
Open Access | Times Cited: 3
Coagulopathy and thromboembolic events a pathogenic mechanism of COVID‐19 associated with mortality: An updated review
Parastoo Yousefi, Saber Soltani, Goli Siri, et al.
Journal of Clinical Laboratory Analysis (2023) Vol. 37, Iss. 11-12
Open Access | Times Cited: 7
Role of Therapeutic Anticoagulation in COVID-19: The Current Situation
Mandeep Singh Rahi, Jay Parekh, Prachi Pednekar, et al.
Hematology Reports (2023) Vol. 15, Iss. 2, pp. 358-369
Open Access | Times Cited: 6
Anticoagulant therapy in COVID‐19: A narrative review
Zeinab Mohseni Afshar, Ali Tavakoli Pirzaman, Rezvan Hosseinzadeh, et al.
Clinical and Translational Science (2023) Vol. 16, Iss. 9, pp. 1510-1525
Open Access | Times Cited: 6
COVID-19: A Pediatric Update in Epidemiology, Management, Prevention, and Long-term Effects
Kengo Inagaki, Charlotte V. Hobbs
Pediatrics in Review (2023) Vol. 44, Iss. 5, pp. 243-254
Closed Access | Times Cited: 5
Evaluation of a fast‐and‐frugal clinical decision algorithm (‘pathways’) on clinical outcomes in hospitalised patients with COVID‐19 treated with anticoagulants
Benjamin Djulbegović, Iztok Hozo, David Lizarraga, et al.
Journal of Evaluation in Clinical Practice (2022) Vol. 29, Iss. 1, pp. 3-12
Open Access | Times Cited: 9
Postoperative Outcomes in Patients Undergoing Orthopedic Surgery Within 90 Days of Coronavirus Disease 2019
Andrea H Johnson, Laura A. Stock, Benjamin M. Petre, et al.
Journal of the American Academy of Orthopaedic Surgeons (2022)
Closed Access | Times Cited: 9
Omicron, Long-COVID, and the Safety of Elective Surgery for Adults and Children: Joint Guidance from the Therapeutics and Guidelines Committee of the Surgical Infection Society and the Surgery Strategic Clinical Network, Alberta Health Services
Philip S. Barie, Mary E. Brindle, Rachel G. Khadaroo, et al.
Surgical Infections (2022) Vol. 24, Iss. 1, pp. 6-18
Closed Access | Times Cited: 9
Barriers to and facilitators of living guidelines use in low-income and middle-income countries: a scoping review
Bekele Tesfaye Meteku, Matthew Quigley, Tari Turner, et al.
BMJ Open (2024) Vol. 14, Iss. 1, pp. e074311-e074311
Open Access | Times Cited: 1
Converting IMPROVE bleeding and VTE risk assessment models into a fast-and-frugal decision tree for optimal hospital VTE prophylaxis
Benjamin Djulbegović, Alice M. Boylan, Shelby J. Kolo, et al.
Blood Advances (2024) Vol. 8, Iss. 12, pp. 3214-3224
Open Access | Times Cited: 1
Venous Thromboembolic Disease in COVID-19, Pathophysiology, Therapy and Prophylaxis
Małgorzata Dybowska, Dorota Wyrostkiewicz, Lucyna Opoka, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 18, pp. 10372-10372
Open Access | Times Cited: 8
Incidence of lower limb deep vein thrombosis in patients with COVID-19 pneumonia through different waves of SARS-CoV-2 pandemic: A multicenter prospective study
Filippo Pieralli, Fulvio Pomero, Lorenzo Corbo, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0280247-e0280247
Open Access | Times Cited: 4
Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis
Hyeon‐Jeong Lee, Hye Jin Jang, Won-Il Choi, et al.
Acute and Critical Care (2023) Vol. 38, Iss. 2, pp. 160-171
Open Access | Times Cited: 4
Association between antithrombotic therapy and mortality in patients hospitalized for COVID‑19
Xing Wang, Wuqian Chen, Jiulin Guo, et al.
Thrombosis Journal (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Tissue Factor Pathway Inhibitor and Interleukin-1 Receptor Levels in COVID-19
Diana A. Gorog, Brijesh Patel
Thrombosis and Haemostasis (2024) Vol. 124, Iss. 08, pp. 721-724
Closed Access | Times Cited: 1
Thromboembolic Disease in Patients With Cancer and COVID-19: Risk Factors, Prevention and Practical Thromboprophylaxis Recommendations–State-of-the-Art
Evangelos Dimakakos, Georgia Gomatou, M. Catalano, et al.
Anticancer Research (2022) Vol. 42, Iss. 7, pp. 3261-3274
Open Access | Times Cited: 7
Risk of posthospital venous thromboembolism in patients with COVID-19 varies by SARS-CoV-2 period and vaccination status
Nareg H. Roubinian, David R. Vinson, Tess Knudson-Fitzpatrick, et al.
Blood Advances (2022) Vol. 7, Iss. 1, pp. 141-144
Open Access | Times Cited: 7
Page 1 - Next Page

Scroll to top